News Agency
Men's Weekly

JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus

  • Written by PR Newswire

SHANGHAI, April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA) of Chin...

Read more: JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with...

How Headless CMS Enhances Responsive Design and Layout Flexibility

Image by freepik As digital technology continues to evolve at a breakneck pace, users expect much more from content than ever before, and responsive design is crucial to ensure content not only looks but operates across all screens. No longer are... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion